中华麻醉学杂志
中華痳醉學雜誌
중화마취학잡지
CHINESE JOURNAL OF ANESTHESIOLOGY
2013年
1期
49-50
,共2页
曹振刚%唐丽%周亦%孙明明%古昌剑%李新成
曹振剛%唐麗%週亦%孫明明%古昌劍%李新成
조진강%당려%주역%손명명%고창검%리신성
舒芬太尼%二异丙酚%维吾尔族%剂量效应关系,药物%药物释放系统
舒芬太尼%二異丙酚%維吾爾族%劑量效應關繫,藥物%藥物釋放繫統
서분태니%이이병분%유오이족%제량효응관계,약물%약물석방계통
Sufentanil%Propofol%UYGUR NATIONALITY%Dose-response relationship,drug%Drug delivery systems
目的 确定复合异丙酚时舒芬太尼抑制维吾尔族患者气管插管心血管反应的半数有效效应室靶浓度(EC50).方法 全身麻醉下择期手术的维吾尔族患者31例,年龄21~59岁,性别不限,BMI 18~28 kg/m2,ASA分级Ⅰ或Ⅱ级.麻醉诱导:靶控输注异丙酚,效应室靶浓度为3.0 μg/ml,静脉注射顺阿曲库铵0.2 mg/kg,靶控输注舒芬太尼,第1例患者效应室靶浓度为0.8 ng/ml,待效应室靶浓度与血浆靶浓度达平衡后行气管插管,发生气管插管心血管反应时,则下一例患者采用高一级浓度,否则采用低一级浓度,浓度梯度的比值为1.1.发生气管插管心血管反应的标准:收缩压升高幅度超过基础值15%和(或)心率>90次/min且持续时间>15s.采用Probit概率回归法计算舒芬太尼抑制气管插管心血管反应的EC50及其95%可信区间.结果 复合异丙酚时舒芬太尼抑制维吾尔族患者气管插管心血管反应的EC50及其95%可信区间为0.46(0.43~0.49)ng/ml.结论 复合异丙酚时,舒芬太尼抑制维吾尔族患者气管插管心血管反应的EC50为0.46 ng/ml.
目的 確定複閤異丙酚時舒芬太尼抑製維吾爾族患者氣管插管心血管反應的半數有效效應室靶濃度(EC50).方法 全身痳醉下擇期手術的維吾爾族患者31例,年齡21~59歲,性彆不限,BMI 18~28 kg/m2,ASA分級Ⅰ或Ⅱ級.痳醉誘導:靶控輸註異丙酚,效應室靶濃度為3.0 μg/ml,靜脈註射順阿麯庫銨0.2 mg/kg,靶控輸註舒芬太尼,第1例患者效應室靶濃度為0.8 ng/ml,待效應室靶濃度與血漿靶濃度達平衡後行氣管插管,髮生氣管插管心血管反應時,則下一例患者採用高一級濃度,否則採用低一級濃度,濃度梯度的比值為1.1.髮生氣管插管心血管反應的標準:收縮壓升高幅度超過基礎值15%和(或)心率>90次/min且持續時間>15s.採用Probit概率迴歸法計算舒芬太尼抑製氣管插管心血管反應的EC50及其95%可信區間.結果 複閤異丙酚時舒芬太尼抑製維吾爾族患者氣管插管心血管反應的EC50及其95%可信區間為0.46(0.43~0.49)ng/ml.結論 複閤異丙酚時,舒芬太尼抑製維吾爾族患者氣管插管心血管反應的EC50為0.46 ng/ml.
목적 학정복합이병분시서분태니억제유오이족환자기관삽관심혈관반응적반수유효효응실파농도(EC50).방법 전신마취하택기수술적유오이족환자31례,년령21~59세,성별불한,BMI 18~28 kg/m2,ASA분급Ⅰ혹Ⅱ급.마취유도:파공수주이병분,효응실파농도위3.0 μg/ml,정맥주사순아곡고안0.2 mg/kg,파공수주서분태니,제1례환자효응실파농도위0.8 ng/ml,대효응실파농도여혈장파농도체평형후행기관삽관,발생기관삽관심혈관반응시,칙하일례환자채용고일급농도,부칙채용저일급농도,농도제도적비치위1.1.발생기관삽관심혈관반응적표준:수축압승고폭도초과기출치15%화(혹)심솔>90차/min차지속시간>15s.채용Probit개솔회귀법계산서분태니억제기관삽관심혈관반응적EC50급기95%가신구간.결과 복합이병분시서분태니억제유오이족환자기관삽관심혈관반응적EC50급기95%가신구간위0.46(0.43~0.49)ng/ml.결론 복합이병분시,서분태니억제유오이족환자기관삽관심혈관반응적EC50위0.46 ng/ml.
Objective To determine the median effective target effect-site concentration (EC50) of sufentanil inhibiting cardiovascular response to tracheal intubation when combined with propofol in patients of Uygur nationality.Methods Thirty-one ASA Ⅰ or Ⅱ Uighurs of both sexes,aged 21-59 yr,with body mass index 18-28 kg/m2,undergoing elective surgery,were enrolled in this study.Anesthesia was induced and maintained with propofol and sufentanil target-controlled infusion and iv injection of cisatracurium 0.2 mg/kg.The target effect-site concentration (Ce) of propofol was set at 3.0 μg/ml.Tracheal intubation was performed after the target Ce and plasma concentrations were balanced.The target Ce was set at 0.8 ng/ml in the first patient.Each time Ce increased/decreased by 10% in the next patient depending on whether or not the cardiovascular response to tracheal intubation occurred.The positive cardiovascular response was defined as increase in systolic blood pressure by 15% and/or HR> 90 bpm lasting for > 15 s.The EC50(95% confidence interval) of sufentanil blunting cardiovascular responses to trancheal intubation was calculated by Probit analysis.Results EC50 (95 % confidence interval) of sufentanil inhibiting cardiovascular response to tracheal intubation when combined with 3.0 μg/ml propofol was 0.46 (0.43-0.49) ng/ml.Conclusion EC50 of sufentanil inhibiting cardiovascular response to tracheal intubation is 0.46 ng/ml in patients of Uygur nationality when combined with propofol.